Suppr超能文献

依那普利对急性感染后肾小球肾炎患儿血压及超声心动图参数的影响。

Enalapril influence on blood pressure and echocardiographic parameters in children with acute postinfectious glomerulonephritis.

作者信息

Jankauskiene Augustina, Cerniauskiene Vilija, Jakutovic Marija, Malikenas Arūnas

机构信息

Vilnius University Children's Hospital, Vilnius, Lithuania.

出版信息

Medicina (Kaunas). 2005;41(12):1019-25.

Abstract

UNLABELLED

The aim of the study was to evaluate the effects of early treatment with the angiotensin-converting enzyme inhibitor, enalapril, on the blood pressure and left ventricular diameters and function in children suffering from acute postinfectious glomerulonephritis.

PATIENTS AND METHODS

A total of 51 children with acute postinfectious glomerulonephritis were involved in the study. Out of them, 26 patients were treated with enalapril for 6 weeks, 25 patients served as their controls. Their blood pressure was measured every other day in the early course of the disease, after 6-8 weeks, and after 6 months. 2D, M-mode, pulsed-wave Doppler echocardiography were performed on 18 enalapril treated patients and 14 controls on admission to the hospital and after 6-8 weeks.

RESULTS

An earlier decline in blood pressure was found in the enalapril treated patients, with no difference between the groups at 6 months after onset of acute postinfectious glomerulonephritis. Comparison of the echocardiographic findings at the onset of acute postinfectious glomerulonephritis and after 6-8 weeks of enalapril treatment showed a significant decrease of left ventricular end-diastolic diameter (4.42+/-0.71 cm before treatment vs. 4.19+/-0.69 after treatment, p<0.001), left ventricular end-systolic diameter (2.81+/-0.59 cm vs. 2.64+/-0.48 cm, respectively, p=0.04), left ventricular mass (102.56+/-51.86 g vs. 86.77+/-43.54 g, p<0.001), and mitral peak flow velocity of late filling (0.54+/-0.11 m/s vs. 0.49+/-0.09 m/s, p=0.02). Other parameters, although statistically nonsignificant, showed better improvement in the enalapril treated patients than in those untreated. In the enalapril untreated group, echocardiographic parameters did not change significantly.

CONCLUSION

A better antihypertensive effect was found in the enalapril treated patients, as well as better improvement of echocardiographic parameters, early in the disease. Whether these effects of enalapril have some influence on the outcome of acute postinfectious glomerulonephritis requires further study.

摘要

未标记

本研究的目的是评估血管紧张素转换酶抑制剂依那普利早期治疗对急性感染后肾小球肾炎患儿血压、左心室直径和功能的影响。

患者与方法

共有51例急性感染后肾小球肾炎患儿参与本研究。其中,26例患者接受依那普利治疗6周,25例患者作为对照。在疾病早期、6 - 8周后及6个月后每隔一天测量他们的血压。对18例接受依那普利治疗的患者和14例对照患者在入院时及6 - 8周后进行二维、M型、脉冲波多普勒超声心动图检查。

结果

接受依那普利治疗的患者血压下降更早,在急性感染后肾小球肾炎发病6个月时两组之间无差异。急性感染后肾小球肾炎发病时与依那普利治疗6 - 8周后的超声心动图检查结果比较显示,左心室舒张末期直径显著减小(治疗前4.42±0.71 cm,治疗后4.19±0.69 cm,p<0.001),左心室收缩末期直径(分别为2.81±0.59 cm和2.64±0.48 cm,p = 0.04),左心室质量(102.56±51.86 g和86.77±43.54 g,p<0.001),以及二尖瓣晚期充盈峰值流速(0.54±0.11 m/s和0.49±0.09 m/s,p = 0.02)。其他参数虽然无统计学意义,但在接受依那普利治疗的患者中比未治疗患者改善更好。在未接受依那普利治疗的组中,超声心动图参数无显著变化。

结论

接受依那普利治疗的患者降压效果更好,且在疾病早期超声心动图参数改善也更好。依那普利的这些作用是否对急性感染后肾小球肾炎的结局有影响需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验